Leslie Iltgen
Investor Relations Contact bij HENKEL AG & CO. KGAA
Profiel
Leslie Iltgen is currently the Head-Investor Relations at Henkel AG & Co. KGaA since 2022.
Prior to this, she held the position of Vice President-Investor Relations at Fresenius SE & Co. KGaA, STADA Arzneimittel AG, and Senior VP-Communications & Investor Relations at DEUTZ AG from 2018 to 2020.
She also worked as a Research Analyst at Bankhaus Lampe KG (Broker).
At Jenoptik AG, she was the Head-Investor Relations & Corporate Communications.
Actieve functies van Leslie Iltgen
| Bedrijven | Functie | Begin |
|---|---|---|
| HENKEL AG & CO. KGAA | Investor Relations Contact | 15-09-2022 |
Eerdere bekende functies van Leslie Iltgen
| Bedrijven | Functie | Einde |
|---|---|---|
| DEUTZ AG | Investor Relations Contact | 01-12-2020 |
| JENOPTIK AG | Investor Relations Contact | - |
| FRESENIUS SE & CO. KGAA | Public Communications Contact | - |
| STADA ARZNEIMITTEL | Investor Relations Contact | - |
| Bankhaus Lampe KG (Broker) | Analyst-Equity | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| FRESENIUS SE & CO. KGAA | Health Technology |
| HENKEL AG & CO. KGAA | Consumer Non-Durables |
| JENOPTIK AG | Electronic Technology |
| DEUTZ AG | Producer Manufacturing |
| Bedrijven in privébezit | 2 |
|---|---|
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
| Bankhaus Lampe KG (Broker) | Finance |
